These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 25723557)

  • 1. Minimal clinically important differences in health-related quality of life after treatment with direct-acting antivirals for chronic hepatitis C: ANRS CO22 HEPATHER cohort (PROQOL-HCV).
    Abbas M; Patrizia C; Fabienne M; Marc B; Lucia P; Fabrice C; Martin D; Camelia P
    Qual Life Res; 2024 Jun; 33(6):1527-1540. PubMed ID: 38580786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The International development of PROQOL-HCV: An instrument to assess the health-related quality of life of patients treated for Hepatitis C virus.
    Armstrong AR; Herrmann SE; Chassany O; Lalanne C; Da Silva MH; Galano E; Carrieri PM; Estellon V; Sogni P; Duracinsky M
    BMC Infect Dis; 2016 Aug; 16(1):443. PubMed ID: 27553866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A generalized additive model to disentangle age and diagnosis-specific cohort effects in psychological and behavioral outcomes in people living with HIV: the French cross-sectional ANRS-VESPA2 survey.
    Sagaon-Teyssier L; Vilotitch A; Mora M; Maradan G; Guagliardo V; Suzan-Monti M; Dray-Spira R; Spire B;
    BMC Public Health; 2019 May; 19(1):590. PubMed ID: 31101129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceived health-related quality of life in people living with HIV co-infected with SARS-CoV-2 in France.
    Amboise Y; Yaya I; Yombo-Kokule L; Roucoux G; Ossima AN; Preau M; Griffith JW; Marcellin F; Chassany O; Cheret A; Duracinsky M
    Qual Life Res; 2024 Jun; ():. PubMed ID: 38865069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective cohort study of liver transplantation in the United Kingdom between 1994 and 2010: the impact of hepatitis C infection.
    Edeghere O; Verlander NQ; Aboulhab J; Costella A; Harris HE; Balogun MA; Ramsay ME
    Public Health; 2015 May; 129(5):509-16. PubMed ID: 25726124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus and coinfection with hepatitis B and C.
    Petty LA; Steinbeck JL; Pursell K; Jensen DM
    Infect Dis Clin North Am; 2014 Sep; 28(3):477-99. PubMed ID: 25151567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life of people living with HIV followed up in hospitals in France: comparing trends and correlates between 2003 and 2011 (ANRS-VESPA and VESPA2 national surveys).
    Douab T; Marcellin F; Vilotitch A; Protopopescu C; Préau M; Suzan-Monti M; Sagaon-Teyssier L; Lert F; Carrieri MP; Dray-Spira R; Spire B;
    AIDS Care; 2014; 26 Suppl 1():S29-40. PubMed ID: 24731158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study.
    Molina JM; Orkin C; Iser DM; Zamora FX; Nelson M; Stephan C; Massetto B; Gaggar A; Ni L; Svarovskaia E; Brainard D; Subramanian GM; McHutchison JG; Puoti M; Rockstroh JK;
    Lancet; 2015 Mar; 385(9973):1098-106. PubMed ID: 25659285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High HCV treatment uptake in the Swedish HIV/HCV co-infected cohort.
    Stenkvist J; Weiland O; Sönnerborg A; Blaxhult A; Falconer K
    Scand J Infect Dis; 2014 Sep; 46(9):624-32. PubMed ID: 24984040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of patients' socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patients.
    Yaya I; Roux P; Marcellin F; Wittkop L; Esterle L; Spire B; Dominguez S; Elegbe BA; Piroth L; Sogni P; Salmon-Ceron D; Carrieri MP;
    PLoS One; 2018; 13(7):e0199874. PubMed ID: 29975764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous and post-treatment HCV clearance: relationships with health-related quality of life in HIV infection (ANRS-VESPA2 study).
    Marcellin F; Demoulin B; Spire B; Suzan-Monti M; Roux P; Protopopescu C; Sagaon-Teyssier L; Duracinsky M; Dray-Spira R; Carrieri MP;
    Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):701-13. PubMed ID: 25723557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort.
    Marcellin F; Roux P; Winnock M; Lions C; Dabis F; Salmon-Ceron D; Loko MA; Spire B; Carrieri MP
    Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):351-8. PubMed ID: 24580042
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.